Men's Health News

RSS

Stopping prostate cancer cells from 'bulking up' with nutrients blocks spread of disease

Cancer Research UK scientists have discovered that stopping prostate cancer cells from 'bulking up' with nutrients reduces the spread of the disease and tumour size, according to research published today in EMBO Journal.

21 May 2011

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

For my money, the most interesting thing about Mitt Romney's health-care speech last week wasn't his struggle to defend Romneycare and distance it from Obamacare, but the largely hostile reception of the speech from the right.

20 May 2011

Cell phones increase testosterone level, but decrease fertility in men

Men who have been diagnosed with poor sperm quality and who are trying to have children should limit their cell phone use. Researchers have found that while cell phone use appears to increase the level of testosterone circulating in the body, it may also lead to low sperm quality and a decrease in fertility.

20 May 2011

Advantagene reaches SPA agreement with FDA for ProstAtak Phase 3 trial to prevent prostate cancer recurrence

Advantagene, Inc., a Massachusetts-based biopharmaceutical company, announced today that it reached an agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment (SPA) for a pivotal Phase 3 clinical trial of ProstAtak™, its lead agent for patients with newly diagnosed prostate cancer.

19 May 2011

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Mitomics, world leader in the research and development of mitochondrial genome-based products, today announced it has entered into a non-exclusive licensing agreement with QDx Pathology Services to develop, market and process the QPredict™ Prostate Mitomic Test.

19 May 2011

Treadmill test helps predict lifetime risk of cardiovascular disease in middle-age people

In two separate studies, UT Southwestern Medical Center researchers have found that how fast a middle-age person can run a mile can help predict the risk of dying of heart attack or stroke decades later for men and could be an early indicator of cardiovascular disease for women.

19 May 2011

Silodosin helps reduce chronic prostatitis in men

New findings show that treatment with a specific alpha blocker helps reduce symptoms and improve quality of life for men with chronic prostatitis/chronic pelvic pain syndrome.

18 May 2011

New denosumab Phase III trial data in high-risk prostate cancer presented at AUA conference

Data on the use of denosumab (Xgeva) to improve bone metastases-free survival in men with high-risk prostate cancer was presented at the American Urological Association conference today for the first time.

18 May 2011

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

Amgen today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone.

18 May 2011

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.

18 May 2011

Coffee reduces prostate cancer risk

In the 20-year study of almost 50,000 men, researchers noted that those who drank at least six cups a day were 20 per cent less likely to get prostate cancer than those who never took coffee. Strikingly, they were 60 per cent less likely than the non-coffee drinkers to die of the disease. The researchers also say that decaffeinated coffee is just as effective.

17 May 2011

Uganda launches PEPFAR-supported mobile male circumcision clinic

U.S. Ambassador to Uganda Jerry Lanier on Friday in Kampala launched a Mobile Medical Male Circumcision clinic, a project of the PEPFAR-supported Makerere University Walter Reed Project, New Vision reports.

17 May 2011

New A+PSA assay more accurately detects prostate cancer

A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

17 May 2011

UW's ultrathin laser endoscope gives a Google Earth view of the bladder

Bladder cancer is the fourth-most-common cancer in men and one of the most expensive cancers to treat from diagnosis to death. After initial diagnosis and surgery, patients must return to the urologist at least yearly for a costly, time-consuming and uncomfortable bladder scan. Tumors recur in more than half of patients.

17 May 2011

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Researchers have linked a variant in the vitamin D receptor gene (VDR) with the onset of chronic obstructive pulmonary disease (COPD) in Caucasian men. The study population consisted of participants in the Veterans Administration Normative Aging Study, a multidisciplinary study of aging that began in 1963.

16 May 2011

Men's Health News

Stopping prostate cancer cells from 'bulking up' with nutrients blocks spread of disease

Longer looks: Tough health care questions for GOP presidential contenders; Robotics help spike use of prostate treatment

Cell phones increase testosterone level, but decrease fertility in men

Advantagene reaches SPA agreement with FDA for ProstAtak Phase 3 trial to prevent prostate cancer recurrence

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Treadmill test helps predict lifetime risk of cardiovascular disease in middle-age people

Silodosin helps reduce chronic prostatitis in men

New denosumab Phase III trial data in high-risk prostate cancer presented at AUA conference

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

Coffee reduces prostate cancer risk

Uganda launches PEPFAR-supported mobile male circumcision clinic

New A+PSA assay more accurately detects prostate cancer

UW's ultrathin laser endoscope gives a Google Earth view of the bladder

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Insight into male infertility

Obese men may face high risk of prostate cancer progression

Stress related to pregnancy affects health of expectant parents and their infants

New circumcision treatment can reduce HIV

Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News